AI-driven precision medicine, forecasting disease progression
Perceiv is an AI-based healthcare company specializing in the field of precision medicine. We are dedicated to help improving and saving patient lives through more efficient, accurate, subject targeting, and objective prognosis through advanced machine learning algorithms.Diseases are more complex than they appear resulting in problems when finding the right population to treat and demonstrate treatment efficacy. We help pharmaceutical companies improve their chances of success by identifying the right subjects for their clinical trials using our AI-driven precision medicine platform. We specialize in the identification of subpopulations of interest in heterogeneous data and complex diseases.Perceiv is currently developing applications in age-related diseases notably CNS/Alzheimer's disease and cardiovascular indications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2022 | Seed | $1.50M | 6 | — | — | Detail |
Nov 5, 2020 | Grant | $300K | — | — | — | Detail |
Apr 4, 2020 | Grant | $150K | — | — | — | Detail |
Sep 1, 2019 | Non-Equity Assistant | $35K | 1 | Centech | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Centech | Yes | Non-Equity Assistant |
Boreal Ventures | — | Seed |
Center of Aging and Brain Health Innovation | — | Seed |
IKJ Capital | — | Seed |
Investissement Quebec | — | Seed |
Plug and Play | — | Seed |
Red Abbey Venture Partners | — | Seed |